ZILIOLI, VITTORIO RUGGERO
ZILIOLI, VITTORIO RUGGERO
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation
2005 C. Annaloro, V.R. Zilioli, N.S. Fracchiolla, C. Vener, D. Soligo, A. Della Volpe, G. LAMBERTENGHI DELILIERS
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H
2006 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, G. Lambertenghi-Deliliers, M. Colombo, P. Lampertico
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Low-dose subcutaneous alemtuzumab therapy for patients with refractory chronic lymphoblastic leukaemia (B-CLL)
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, F. Somalvico, G. LAMBERTENGHI DELILIERS
Safety and efficacy of low-dose subcuteneous campath-1H therapy in patients with refractory chronic lymphocytic leukaemia
2005 A. Cortelezzi, M.C. Pasquini, N.N. Fantini, V.R. Zilioli, M. Colombi, B. Sarina, G. Lambertenghi Deliliers
Treatment with hydroxyurea as single agent does not increase the risk of second malignancies in essential thrombocytopenia patients
2006 F. Radaelli, F. Onida, F. Rossi, M. Colombi, V.R. Zilioli, F. Somalvico, A. Zanella